Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medifast (MED) Tax Provisions (2016 - 2025)

Medifast's Tax Provisions history spans 16 years, with the latest figure at $11.7 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 2246.6% year-over-year to $11.7 million; the TTM value through Dec 2025 reached $13.0 million, up 656.85%, while the annual FY2025 figure was $13.0 million, 666.65% up from the prior year.
  • Tax Provisions reached $11.7 million in Q4 2025 per MED's latest filing, up from -$400000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $14.4 million in Q2 2021 to a low of -$2.5 million in Q2 2024.
  • Average Tax Provisions over 5 years is $6.8 million, with a median of $7.4 million recorded in 2022.
  • The largest YoY upside for Tax Provisions was 2246.6% in 2025 against a maximum downside of 189.09% in 2025.
  • A 5-year view of Tax Provisions shows it stood at $12.7 million in 2021, then crashed by 53.72% to $5.9 million in 2022, then crashed by 36.04% to $3.8 million in 2023, then plummeted by 86.73% to $500000.0 in 2024, then skyrocketed by 2246.6% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Tax Provisions are $11.7 million (Q4 2025), -$400000.0 (Q3 2025), and $400000.0 (Q2 2025).